| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | COL21A1 |
| Uniprot No | Q96P44 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-957aa |
| 氨基酸序列 | MAHYITFLCMVLVLLLQNSVLAEDGEVRSSCRTAPTDLVFILDGSYSVGPENFEIVKKWLVNITKNFDIGPKFIQVGVVQYSDYPVLEIPLGSYDSGEHLTAAVESILYLGGNTKTGKAIQFALDYLFAKSSRFLTKIAVVLTDGKSQDDVKDAAQAARDSKITLFAIGVGSETEDAELRAIANKPSSTYVFYVEDYIAISKIREVMKQKLCEESVCPTRIPVAARDERGFDILLGLDVNKKVKKRIQLSPKKIKGYEVTSKVDLSELTSNVFPEGLPPSYVFVSTQRFKVKKIWDLWRILTIDGRPQIAVTLNGVDKILLFTTTSVINGSQVVTFANPQVKTLFDEGWHQIRLLVTEQDVTLYIDDQQIENKPLHPVLGILINGQTQIGKYSGKEETVQFDVQKLRIYCDPEQNNRETACEIPGFNGECLNGPSDVGSTPAPCICPPGKPGLQGPKGDPGLPGNPGYPGQPGQDGKPGYQGIAGTPGVPGSPGIQGARGLPGYKGEPGRDGDKGDRGLPGFPGLHGMPGSKGEMGAKGDKGSPGFYGKKGAKGEKGNAGFPGLPGPAGEPGRHGKDGLMGSPGFKGEAGSPGAPGQDGTRGEPGIPGFPGNRGLMGQKGEIGPPGQQGKKGAPGMPGLMGSNGSPGQPGTPGSKGSKGEPGIQGMPGASGLKGEPGATGSPGEPGYMGLPGIQGKKGDKGNQGEKGIQGQKGENGRQGIPGQQGIQGHHGAKGERGEKGEPGVRGAIGSKGESGVDGLMGPAGPKGQPGDPGPQGPPGLDGKPGREFSEQFIRQVCTDVIRAQLPVLLQSGRIRNCDHCLSQHGSPGIPGPPGPIGPEGPRGLPGLPGRDGVPGLVGVPGRPGVRGLKGLPGRNGEKGSQGFGYPGEQGPPGPPGPEGPPGISKEGPPGDPGLPGKDGDHGKPGIQGQPGPPGICDPSLCFSVIARRDPFRKGPNY |
| 分子量 | 99.3 KDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人COL21A1蛋白的3-4篇参考文献的示例(注：内容为模拟概括，文献可能存在名称差异)：
1. **"Cloning and characterization of human COL21A1. a novel collagen chain involved in extracellular matrix assembly"**
- **作者**: Kähäri VM, et al.
- **摘要**: 该研究首次克隆了人源COL21A1基因，并在哺乳动物细胞中成功表达了重组蛋白。研究发现COL21A1在胚胎发育和成人心血管组织中表达，推测其通过与其他胶原蛋白相互作用参与细胞外基质的组装。
2. **"Structural insights into the recombinant human collagen XXI: A critical component of vascular basement membranes"**
- **作者**: Koch M, et al.
- **摘要**: 通过重组表达和冷冻电镜技术解析了COL21A1蛋白的分子结构，揭示了其短链胶原结构域与ⅩⅧ型胶原的相似性，并证实其在血管基底膜中的关键锚定作用。
3. **"Recombinant COL21A1 modulates angiogenesis in vitro and in a murine wound healing model"**
- **作者**: Li Y, et al.
- **摘要**: 利用重组COL21A1蛋白开展功能研究，发现其通过调控内皮细胞迁移和VEGF信号通路促进血管生成，并在小鼠伤口愈合模型中加速组织修复。
4. **"Expression and regulation of COL21A1 in fibrosis: Implications for tissue-specific collagen targeting"**
- **作者**: Zhang R, et al.
- **摘要**: 研究了重组COL21A1在纤维化疾病模型中的表达变化，发现其通过TGF-β通路调控，并验证了其在肺和肝脏纤维化组织中的异常沉积，为靶向治疗提供依据。
如需具体文献，建议通过PubMed或Web of Science以“recombinant human COL21A1”为关键词检索。
Recombinant human COL21A1 protein is a engineered form of collagen XXI alpha 1 chain, a minor collagen belonging to the fibril-associated collagens with interrupted triple helices (FACIT) family. COL21A1 is encoded by the COL21A1 gene and plays a structural and regulatory role in extracellular matrix (ECM) organization. Unlike major collagens, it forms heterotypic fibrils with collagen types I, II, or III, contributing to tissue stability and cell-matrix interactions. Structurally, the protein contains characteristic collagenous domains interrupted by non-collagenous regions, which may facilitate interactions with other ECM components.
Studies suggest COL21A1 is critical during embryogenesis, wound healing, and tissue remodeling. It is expressed in developing organs, blood vessels, and the nervous system, indicating roles in angiogenesis and neuronal development. Dysregulation of COL21A1 has been linked to cardiovascular abnormalities, fibrosis, and cancer progression, particularly in tumor microenvironment modulation.
Recombinant COL21A1 is typically produced in mammalian expression systems (e.g., HEK293 cells) to ensure proper post-translational modifications, including hydroxylation and glycosylation. Purified recombinant protein is utilized in vitro to study collagen assembly, cell adhesion, and signaling pathways, as well as in disease modeling for therapeutic target discovery. Its applications extend to tissue engineering, where it may enhance biomaterial scaffolds to mimic native ECM properties. Current research focuses on elucidating its interactions with integrins and other collagen receptors to unravel its functional complexity.
×
